Company Team
Co-founder & CEO
Dr. Sean Li
- 30+ yrs experience in peptide chemistry and biology
- 10 yrs CRO experience in peptide technology and services. Former Exec. Director of Peptide Technology and Services in WuXi AppTec
- Ph.D. in Chemistry from Peking University; Postdoc at Purdue, University of Maryland and Osaka University
Senior Vice President Drug Discovery
Dr. Henry Liu
- 25+ yrs of industrial research and management experience in drug screening, pharmacology from early discovery to preclinical late stage
- Former Director of Neurorscience in Chempartner; V.P. of Biology in PharmaCore Labs; Scientist at Icagen Inc. & Neuromed.
- M.D. in Clinical Medicine/Cardiac Surgery from Peking University
Executive Director, In Vitro Biology
Dr. Shiu-Feng Tung
- 20+ yrs of industrial and academic research experience in high throughput screening, assay development and receptor pharmacology
- Former Senior Dzirector of R&D at Tripartite Therapeutics; Supervisor of Taipai Facility at Arena Pharmaceuticals; Director of High Throughput Screening and Receptor Pharmacology at TaiGen Biotechnology; Principal Investigator of GPCR Project at Development Center for Biotechnology
- Ph.D. in Life Science from Institute of Life Science, Academia Sinica/National Health Research Institute/National Defense Medical Center Joint Program
Executive Director, R&D Strategy
Dr. Wenge Liu
- 20+ yrs of industrial and academic research experience in DMPK, drug delivery life cycle management
- Former V.P. of Hainan R&D Center at Simcere Pharma; Senior Director of DPMK at Senior Director of DMPK Suzhou Wuxi AppTech; Research Professor, Biomedical Engineering, Duke University
- M.D. in Medicine from Tianjin Medical University and PhD in Pharmaceutical Sciences from Kumamoto University
Senior Director, Medicinal Chemistry
Dr. Yilong Li
- 10+ years of peptide drug development experience, team leading experience from target/indication selection to PCC/IND
- Former Senzior Principal Scientist at Jiangsu Hengrui Medicine Co.,Senior Scientist at Creative Peptides, Development Scientist PolyPeptide Group
- PhD in Pharmaceutical Sciences at USC
Associate Director, AI Drug Discovery
Dr. Hong Wang
- 14+ yrs of experience in structural biology, X-ray crystallography, single- particle cryo-EM, molecular docking, and dynamic simulation
- Former Postdoctoral Scientist at Boston University Medical Campus
- Ph.D. in Biophysics from the Institute of Biophysics of Chinese Academy of Sciences
Director & Head of Global Business Development
Rumit Maini, Ph.D.
- Over 9 years of experience in peptide drug discovery and platform technologies
- Former Associate Principal Scientist at Merck & Co. (MSD), New Jersey
- PhD in Chemistry from Arizona State University and JSPS postdoctoral fellow at University of Tokyo
PepLib aims to promote the development and accessibility of innovative peptide drugs, benefiting global patients and human health while keeping costs low.
Copyright©2023 Zonsen PepLib Biotech Inc. This website supports IPV6
Business License